SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 6-K
_______________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
_______________
Park Ha Biological Technology Co., Ltd.
(Exact name of registrant as specified in its charter)
_______________
901, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
(Address of Principal Executive Office)
_______________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
2025 Extraordinary General Meeting
In connection with the 2025 extraordinary general meeting of Park Ha Biological Technology Co., Ltd., a Cayman Islands company (the “Company”), the Company hereby furnishes the following documents:
Exhibits
|
Exhibit No. |
Description |
|
|
99.1 |
||
|
99.2 |
Form of Proxy Card to be mailed to the shareholders of the Company |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: November 28, 2025
|
Park Ha Biological Technology Co., Ltd. |
||||
|
By: |
/s/ ZHANG Xiaoqiu |
|||
|
Name: |
ZHANG Xiaoqiu |
|||
|
Title: |
Chief Executive Officer and |
|||
2